Positive hepatitis B surface antigen tests due to recent vaccination: a persistent problem
- PMID: 23006828
- PMCID: PMC3515481
- DOI: 10.1186/1472-6890-12-15
Positive hepatitis B surface antigen tests due to recent vaccination: a persistent problem
Abstract
Background: Hepatitis B virus (HBV) is a common cause of viral hepatitis with significant health complications including cirrhosis and hepatocellular carcinoma. Assays for hepatitis B surface antigen (HBsAg) are the most frequently used tests to detect HBV infection. Vaccination for HBV can produce transiently detectable levels of HBsAg in patients. However, the time course and duration of this effect is unclear. The objective of this retrospective study was to clarify the frequency and duration of transient HBsAg positivity following vaccination against HBV.
Methods: The electronic medical record at an academic tertiary care medical center was searched to identify all orders for HBsAg within a 17 month time period. Detailed chart review was performed to identify all patients who were administered HBV vaccine within 180 days prior to HBsAg testing and also to ascertain likely cause of weakly positive (grayzone) results.
Results: During the 17 month study period, 11,719 HBsAg tests were ordered on 9,930 patients. There were 34 tests performed on 34 patients who received HBV vaccine 14 days or less prior to HBsAg testing. Of these 34 patients, 11 had grayzone results for HBsAg that could be attributed to recent vaccination. Ten of the 11 patients were renal dialysis patients who were receiving HBsAg testing as part of routine and ongoing monitoring. Beyond 14 days, there were no reactive or grayzone HBsAg tests that could be attributed to recent HBV vaccination. HBsAg results reached a peak COI two to three days following vaccination before decaying. Further analysis of all the grayzone results within the 17 month study period (43 results out of 11,719 tests) revealed that only 4 of 43 were the result of true HBV infection as verified by confirmatory testing.
Conclusions: Our study confirms that transient HBsAg positivity can occur in patients following HBV vaccination. The results suggest this positivity is unlikely to persist beyond 14 days post-vaccination. Our study also demonstrates that weakly positive HBsAg results often do not reflect actual HBV infection, underscoring the importance of confirmatory testing. This study also emphasizes that vaccination-induced HBsAg positives occur most commonly in hemodialysis patients.
Figures
Similar articles
-
Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.World J Gastroenterol. 2016 May 21;22(19):4732-40. doi: 10.3748/wjg.v22.i19.4732. World J Gastroenterol. 2016. PMID: 27217704 Free PMC article.
-
Hepatitis B surface antigenemia in chronic hemodialysis patients: effect of hepatitis B immunization.Am J Gastroenterol. 2002 Jan;97(1):138-41. doi: 10.1111/j.1572-0241.2002.05437.x. Am J Gastroenterol. 2002. PMID: 11808938
-
Hepatitis B surface antigenemia following recombinant Engerix B hepatitis B vaccine in an 81-year-old ESRD patient on hemodialysis.Ren Fail. 2010 May;32(4):531-2. doi: 10.3109/08860221003637369. Ren Fail. 2010. PMID: 20446799
-
Chronic hepatitis B virus infection in Asian countries.J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. doi: 10.1046/j.1440-1746.2000.0150121356.x. J Gastroenterol Hepatol. 2000. PMID: 11197043 Review.
-
[Evaluation of viral hepatitis in solid organ transplantation].Acta Med Croatica. 2014 Apr;68(2):151-9. Acta Med Croatica. 2014. PMID: 26012153 Review. Croatian.
Cited by
-
Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial.Lancet Infect Dis. 2020 Sep;20(9):1061-1070. doi: 10.1016/S1473-3099(20)30085-2. Epub 2020 May 6. Lancet Infect Dis. 2020. PMID: 32618279 Free PMC article. Clinical Trial.
-
HBsAg-negative and anti-HBc-positive in eosinophilic granulomatosis with polyangiitis: a retrospective pilot study.Rheumatol Int. 2018 Aug;38(8):1531-1538. doi: 10.1007/s00296-018-4043-z. Epub 2018 May 12. Rheumatol Int. 2018. PMID: 29754328
-
Autoverification in a core clinical chemistry laboratory at an academic medical center.J Pathol Inform. 2014 Mar 28;5(1):13. doi: 10.4103/2153-3539.129450. eCollection 2014. J Pathol Inform. 2014. PMID: 24843824 Free PMC article.
-
The many faces of positive hepatitis B surface antigen.Hepatology. 2016 Oct;64(4):1379-81. doi: 10.1002/hep.28503. Epub 2016 Mar 29. Hepatology. 2016. PMID: 26890893 Free PMC article. No abstract available.
-
Prevalence and incidence rates of laboratory-confirmed hepatitis B infection in South Africa, 2015 to 2019.BMC Public Health. 2022 Jan 6;22(1):29. doi: 10.1186/s12889-021-12391-3. BMC Public Health. 2022. PMID: 34991533 Free PMC article.
References
-
- Janzen L, Minuk GY, Fast M, Bernstein KN. Vaccine-induced hepatitis B surface antigen positivity in adult hemodialysis patients: incidental and surveillance data. J Am Soc Nephrol. 1996;7:1228–1234. - PubMed
LinkOut - more resources
Full Text Sources